login
Nasopharyngeal carcinoma Guangdong Mai Haiqiang Cisplatin
02-09
Nasopharyngeal carcinoma Tripril monoclonal antibody chemotherapy Cancer Prevention and Treatment Center, Sun Yat-sen University Mai Haiqiang
01-24
![Information | Guangdong experts proposed the world's first equivalent low-toxicity program for patients with low-risk nasopharyngeal carcinoma[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)
